ReimbursementCodes - Powerful Tool for Drug Claims and Reimbursement
This page is primarily a product marketing page for ReimbursementCodes, addressing drug pricing and coding challenges in reimbursement workflows, rather than a specific health-plan case study. It includes a testimonial: "I utilize ReimbursementCodes almost on a daily basis. The new platform is amazing." No specific quantified outcomes or before/after metrics — including any $250K/year savings figure — appear on the visible page; content instead focuses on features like HCPCS-to-NDC crosswalks and rebate calculation tools.
The customer is anonymised in Norstella’s own case study — not withheld by us.
Norstella is a holding company merging several pharma-intelligence brands — Citeline (trial intelligence), Evaluate (forecasting), MMIT (payer/formulary data) and Panalgo (real-world analytics) — into one data asset.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Norstella on its own site — read the original case study on mmitnetwork.com ↗
Note: Product marketing page; the specific $250K/year savings figure and health-plan case details are not present on the visible page
Related use cases
- 01Empowering Early Disease Diagnosis with Real-World Data
- 02Refining Rare Disease Targeting with Real-World Data
- 03Gain Real-Time Insights on High-Risk Patient Populations with Real-World Data
- 04Powering Unbiased Outcomes Research with Longitudinal Data
- 05NorstellaLinQ: Better Together: Getting the Full Patient Picture
- 06Trial Rescue & Reconnaissance